Sponsored Links
Caplan: New Mammogram Recommendations Accurate, but Not Right
Blog | blog.bioethics.net | Nov 19, 2009
While the data may support pushing back the timeline for routine mammograms from age 40 to 50 for women, Arthur Caplan questions the decision in his most recent MSNBC column saying that "there is every reason to doubt that the...
http://blog.bioethics.net/2009/11/caplan-new-mammogram-recommendations-accurate-but/
Bionovo: Challenges Ahead, But Poised to Move Higher
Blog | seekingalpha.com | Nov 9, 2009
Three Brothers Health submits:The Womens Health Initiative ('WHI'), a study that demonstrated several lethal side-effects of hormone replacement therapy ('HRT'), has left many pharmaceutical companies
Women Sell Their Eggs, So Why Not a Kidney?
Blog | health.usnews.com | Jul 30, 2009
New Jersey organ trafficking scandal makes me wonder why it’s OK to sell eggs but not organs.
http://health.usnews.com/blogs/on-women/2009/07/28/women-sell-their-eggs-so-why-not-a-kidney.html
Irish Medical Times | The Irish Medical Times Blog | Dieting woman dies from drinking water
Blog | www.imt.ie
(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)
http://www.imt.ie/blogs/irish-Medical-Times-Blog/2008/12/dieting-woman-dies-from-drinki.html
Mental Health | Health Commentary
...Healthy Voices represents all places, races, genders, ages, socio-economic status and occupations -- and it will inform, instruct and ignite a debate on the status of our current health care system and what should be done to improve it...
October FDA Calendar Stocks: Tricks or Treats?
Blog | seekingalpha.com | Oct 16, 2009
Mike Havrilla submits:Below are six stocks from the BioMedReports.com FDA Calendar with expected catalysts during the month of October, including
http://seekingalpha.com/article/166923-october-fda-calendar-stocks-tricks-or-treats?source=feed
Amgen Is a Healthy Buy - Barron's -- Seeking Alpha
Blog | seekingalpha.com | Sep 6, 2009
Amgen (AMGN) is working on a promising bone-loss treatment called denosumab. If, as expected, the treatment gets FDA approval, Barron's Dimitra Defotis explains how the stock could climb from a recent $58.95 to $78.
http://seekingalpha.com/article/160143-amgen-is-a-healthy-buy-barron-s?source=feed
Bio-Reference Laboratories Inc. F3Q09 (Qtr End 07/31/09) Earnings Call Transcript
Blog | seekingalpha.com | Sep 2, 2009
Bio-Reference Laboratories Inc. (BRLI)F3Q09 Earnings CallSeptember 2, 2009; 10:30 am ET<a
Pregnant Women Will Be Included in H1N1 Flu Vaccine Trials
Blog | health.usnews.com | Jul 30, 2009
The government wants expectant moms to get vaccinated first and has decided to include them in trials.
What Regina Benjamin Could Mean to Women's Health
Blog | health.usnews.com | Jul 13, 2009
Certainly, health reform will be her top priority, but what about gender and racial disparities?
